(Q45964348)

18 December 2017

title

Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells. (English)

1 reference

18 December 2017

0 references

4

Michael T Lawton

1 reference

18 December 2017

author name string

Jianhua S Yao

1

1 reference

18 December 2017

Wenwu Zhai

2

1 reference

18 December 2017

Yongfeng Fan

3

1 reference

18 December 2017

Nicholas M Barbaro

5

1 reference

18 December 2017

William L Young

6

1 reference

18 December 2017

Guo-Yuan Yang

7

1 reference

18 December 2017

publication date

5 July 2006

1 reference

18 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

18 December 2017

volume

27

1 reference

18 December 2017

issue

3

1 reference

18 December 2017

page(s)

510-520

1 reference

18 December 2017

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Interleukin-6 involvement in brain arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Gene microarray analysis of human brain arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Increased serum levels of interleukin 6 are associated with severe intraventricular haemorrhage in extremely premature infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Matrix metalloproteinases: they're not just for matrix anymore!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Signaling through beta-catenin and Lef/Tcf

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Gp130 and the interleukin-6 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Influence of VEGF-R2 inhibition on MMP secretion and motility of microvascular human cerebral endothelial cells (HCEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Smooth muscle cell migration stimulated by interleukin 6 is associated with cytoskeletal reorganization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

ECM and cell surface proteolysis: regulating cellular ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

Interleukin-6 in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

Serum interleukin 6 levels become elevated in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600365

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600365

1 reference

18 December 2017

PubMed ID

16820800

1 reference

18 December 2017